Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10072-020-04681-2.pdf
Reference40 articles.
1. Ricci L, Luigetti M, Florio L, Capone F, Di Lazzaro V (2019) Causes of chronic neuropathies: a single-center experience. Neurol Sci 40:1611–1617. https://doi.org/10.1007/s10072-019-03899-z
2. Paul DA, Qureshi ARM, Rana AQ (2020) Peripheral neuropathy in Parkinson's disease. Neurol Sci. https://doi.org/10.1007/s10072-020-04407-4
3. Kreymann B, Williams G, Ghatei MA, Bloom SR (1987) Glucagon-like peptide-1, a physiological incretin in man. Lancet 2:1300–1304. https://doi.org/10.1016/S0140-6736(87)91194-9
4. Perry T, Lahiri DK, Chen D, Zhou J, Shaw KT, Egan JM et al (2002) A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. J Pharmacol Exp Ther 300:958–966. https://doi.org/10.1124/jpet.300.3.958
5. Perry T, Holloway HW, Weerasuriya A, Mouton PR, Duffy K, Mattison JA, Greig NH (2007) Evidence of GLP-1-mediated neuro protection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Exp Neurol 203:293–301. https://doi.org/10.1016/j.expneurol.2006.09.028
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Autonomic modulation by SGLT2i or DPP4i in patients with diabetes favors cardiovascular outcomes as revealed by skin sympathetic nerve activity;Frontiers in Pharmacology;2024-07-30
2. Pleiotropic effect of teneligliptin versus glimepiride add-on therapy on hs-CRP and cardiorenal parameters in Indian type 2 diabetes patients: An open-labeled randomized controlled trial;Perspectives in Clinical Research;2024-07-10
3. Relationship among serum TIMP-1, sCD40L and peripheral neuropathy in type 2 diabetes;Tropical Journal of Pharmaceutical Research;2023-10-08
4. How does diabetic peripheral neuropathy impact patients' burden of illness and the economy? A retrospective study in Beijing, China;Frontiers in Public Health;2023-05-12
5. Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi‐heart study;Diabetes, Obesity and Metabolism;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3